Vermillion to Report Fourth Quarter and Full Year 2016 Financial Results and Host Investor Conference Call on March 29, 2017

Vermillion to Report Fourth Quarter and Full Year 2016 Financial Results and Host Investor Conference Call on March 29, 2017

PR Newswire

AUSTIN, Texas, March 15, 2017 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that it will report its fourth quarter and full year 2016 financial results on Wednesday, March 29, 2017, followed by an investor conference call and webcast at 4:30 p.m. Eastern Time.

Wednesday, March 29th @ 4:30pm Eastern Time.

Domestic:

888-256-1035

International:

913-312-0947

Conference ID:

2832934



Webcast: 

http://public.viavid.com/index.php?id=123159



Replay dial-in numbers, available through April 12th:

Domestic:

844-512-2921

International:

412-317-6671

Replay PIN:

2832934

About Vermillion
Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion, along with its prestigious scientific collaborators, discovers, develops, and delivers innovative diagnostic and technology tools that help women with serious diseases.

Investor Relations Contact:
Michael Wood
LifeSci Advisors LLC
Tel 1-646-597-6983
[email protected]

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vermillion-to-report-fourth-quarter-and-full-year-2016-financial-results-and-host-investor-conference-call-on-march-29-2017-300424249.html

SOURCE Vermillion, Inc.

Copyright CNW Group 2017